These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 27153057)
1. γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current Status. Singh VK; Hauer-Jensen M Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27153057 [TBL] [Abstract][Full Text] [Related]
3. Effects of Gamma-Tocotrienol on Intestinal Injury in a GI-Specific Acute Radiation Syndrome Model in Nonhuman Primate. Garg S; Garg TK; Wise SY; Fatanmi OO; Miousse IR; Savenka AV; Basnakian AG; Singh VK; Hauer-Jensen M Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563033 [TBL] [Abstract][Full Text] [Related]
4. A Metabolomic Serum Signature from Nonhuman Primates Treated with a Radiation Countermeasure, Gamma-tocotrienol, and Exposed to Ionizing Radiation. Pannkuk EL; Laiakis EC; Fornace AJ; Fatanmi OO; Singh VK Health Phys; 2018 Jul; 115(1):3-11. PubMed ID: 29787425 [TBL] [Abstract][Full Text] [Related]
5. A Metabolomic and Lipidomic Serum Signature from Nonhuman Primates Administered with a Promising Radiation Countermeasure, Gamma-Tocotrienol. Cheema AK; Mehta KY; Fatanmi OO; Wise SY; Hinzman CP; Wolff J; Singh VK Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283379 [TBL] [Abstract][Full Text] [Related]
6. Development of gamma-tocotrienol as a radiation medical countermeasure for the acute radiation syndrome: current status and future perspectives. Singh VK; Seed TM Expert Opin Investig Drugs; 2023 Jan; 32(1):25-35. PubMed ID: 36655861 [TBL] [Abstract][Full Text] [Related]
8. Pathology of acute sub-lethal or near-lethal irradiation of nonhuman primates prophylaxed with the nutraceutical, gamma tocotrienol. Singh VK; Wise SY; Fatanmi OO; Petrus SA; Carpenter AD; Lugo-Roman LA; Lee SH; Hauer-Jensen M; Seed TM Sci Rep; 2024 Jun; 14(1):13315. PubMed ID: 38858439 [TBL] [Abstract][Full Text] [Related]
9. Progenitor Cell Mobilization by Gamma-tocotrienol: A Promising Radiation Countermeasure. Singh VK; Fatanmi OO; Verma A; Newman VL; Wise SY; Romaine PL; Berg AN Health Phys; 2016 Aug; 111(2):85-92. PubMed ID: 27356050 [TBL] [Abstract][Full Text] [Related]
10. Gamma-tocotrienol, a radiation countermeasure, reverses proteomic changes in serum following total-body gamma irradiation in mice. Rosen E; Fatanmi OO; Wise SY; Rao VA; Singh VK Sci Rep; 2022 Mar; 12(1):3387. PubMed ID: 35233005 [TBL] [Abstract][Full Text] [Related]
11. Gamma-tocotrienol, a radiation prophylaxis agent, induces high levels of granulocyte colony-stimulating factor. Kulkarni SS; Cary LH; Gambles K; Hauer-Jensen M; Kumar KS; Ghosh SP Int Immunopharmacol; 2012 Dec; 14(4):495-503. PubMed ID: 23000517 [TBL] [Abstract][Full Text] [Related]
12. Development of Orally Administered γ-Tocotrienol (GT3) Nanoemulsion for Radioprotection. Ledet GA; Biswas S; Kumar VP; Graves RA; Mitchner DM; Parker TM; Bostanian LA; Ghosh SP; Mandal TK Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28029115 [TBL] [Abstract][Full Text] [Related]
13. THE POTENTIATION OF THE RADIOPROTECTIVE EFFICACY OF TWO MEDICAL COUNTERMEASURES, GAMMA-TOCOTRIENOL AND AMIFOSTINE, BY A COMBINATION PROPHYLACTIC MODALITY. Singh VK; Fatanmi OO; Wise SY; Newman VL; Romaine PL; Seed TM Radiat Prot Dosimetry; 2016 Dec; 172(1-3):302-310. PubMed ID: 27542813 [TBL] [Abstract][Full Text] [Related]
14. γ-Tocotrienol-Loaded Liposomes for Radioprotection from Hematopoietic Side Effects Caused by Radiotherapeutic Drugs. Lee SG; Kalidindi TM; Lou H; Gangangari K; Punzalan B; Bitton A; Lee CJ; Vargas HA; Park S; Bodei L; Kharas MG; Singh VK; Kishore Pillarsetty NV; Larson SM J Nucl Med; 2021 Apr; 62(4):584-590. PubMed ID: 32826318 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of Neulasta or Neupogen on H-ARS and GI-ARS Mortality and Hematopoietic Recovery in Nonhuman Primates After 10-Gy Irradiation With 2.5% Bone Marrow Sparing. Farese AM; Bennett AW; Gibbs AM; Hankey KG; Prado K; Jackson W; MacVittie TJ Health Phys; 2019 Mar; 116(3):339-353. PubMed ID: 30281533 [TBL] [Abstract][Full Text] [Related]
16. Histopathological studies of nonhuman primates exposed to supralethal doses of total- or partial-body radiation: influence of a medical countermeasure, gamma-tocotrienol. Singh VK; Wise SY; Fatanmi OO; Petrus SA; Carpenter AD; Lee SH; Hauer-Jensen M; Seed TM Sci Rep; 2024 Mar; 14(1):5757. PubMed ID: 38459144 [TBL] [Abstract][Full Text] [Related]
17. Gamma-Tocotrienol Modulates Total-Body Irradiation-Induced Hematopoietic Injury in a Nonhuman Primate Model. Garg TK; Garg S; Miousse IR; Wise SY; Carpenter AD; Fatanmi OO; van Rhee F; Singh VK; Hauer-Jensen M Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555814 [TBL] [Abstract][Full Text] [Related]
18. Gamma-tocotrienol, a tocol antioxidant as a potent radioprotector. Ghosh SP; Kulkarni S; Hieber K; Toles R; Romanyukha L; Kao TC; Hauer-Jensen M; Kumar KS Int J Radiat Biol; 2009 Jul; 85(7):598-606. PubMed ID: 19557601 [TBL] [Abstract][Full Text] [Related]
19. The Effect of Radiation Dose and Variation in Neupogen® Initiation Schedule on the Mitigation of Myelosuppression during the Concomitant GI-ARS and H-ARS in a Nonhuman Primate Model of High-dose Exposure with Marrow Sparing. MacVittie TJ; Bennett AW; Farese AM; Taylor-Howell C; Smith CP; Gibbs AM; Prado K; Jackson W Health Phys; 2015 Nov; 109(5):427-39. PubMed ID: 26425903 [TBL] [Abstract][Full Text] [Related]